Endothelium and high blood pressure

International Journal of Microcirculation-Clinical and Experimental

Volumn 17, Issue 5, 1997, Pages 273-279

  Noll, G ^a   Tschudi, M ^a   Nava, E ^a   Luscher T F ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Endothelium; Hypertension; Nitric oxide

Indexed keywords

ANIMAL; HUMAN; HYPERTENSION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION;

EID: 0031241663     PISSN: 01676865     EISSN: None     Source Type: Journal    
DOI: 10.1159/000179239     Document Type: Article

References (63)

1. Liischcr TF, Vanhoutte PM: The Endothelium: Modulator of Cardiovascular Function, Boca Raton, CRC Press, 1990, pp 1-215.
2. Moncada S, Gryglewski R, Bunting S, Vane JR: An enzyme isolated from arteries transforms prostaglandin endopcroxides to an unstable substance that inhibits platelet aggregation, Nature 1976;263:663-665.
3. Furchgott RF, Zawadski JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature 1980;299:373-376.
4. Palmer RM, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor, Nature 1987:327:524-526.
5. Mombouli JV, Hliano S, Nagao T, Scott-Bur-den T, Vanhoutte PM: Potentiation of endo-thclium-dcpcndcnt relaxations to bradvkinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors, CircRes 1992;71:137-144.
6. Liischcr TF, Boulanger CM, Dohi Y, Yang ZH: Endothelium-derived contracting factors, Hypertension 1992:19:117-130.
7. Yanagisawa M, Kurihara H, Kimura S, To-mobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature 1988,332:411-415.
8. Moncada S, Higgs A: The L-arginine-nitric oxide pathway, N Engl J Med 1993;329:2002-2012.
9. Liischer TF: Mack Forster Award Lecture, Review, The endothelium as a target and mediator of cardiovascular disease, Eur J Clin Invest 1993;23:670-685.
10. Liischer TF: The endothelium and cardiovascular disease - A complex relation (editorial: comment), N Engl J Med 1994:330:1081 - 1083.
11. Bredt DS, Hwang PM, Snyder SH: Localization of nitric oxide synthase indicating a neural role for nitric oxide, Nature 1990:347:768-770.
12. Palmer RM, Ashton DS, Moncada S: Vascular endothelial cells synthesize nitric oxide from L-arginine, Nature 1988:333:664-666.
13. Liischcr TF, Dicderich D, Siebcnntann R, Lehmann K, Stulz P, Von SL, Yang ZH, Turina M, Gradel E, Weber E, Biihler FR: Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts, N Engl J Med 1988:319:462-467.
14. Richard V, Tanner FC, Tschudi M, Liischer TF: Different activation of L-arginine pathway by bradykinin, serotonin, and clonidine in coronary arteries, Am J Physiol 1990;259:H1433-H1439.
15. Noll G, Biihler FR, Yang Z, Liischer TF: Different potency of endothelium-derived relaxing factors against thromboxane, endothelin, and potassium chloride in intramyocardial porcine coronary arteries, J Cardiovasc Pharmacol 1991;18:120-126.
16. Tschudi M, Richard V, Biihler FR, Liischer TF: Importance of endothelium-derived nitric oxide in porcine coronary resistance arteries, Am J Physiol 1991;260:H13-H20.
17. Liischer TF: Endothelium-derived nitric oxide: The endogenous nitrovasodilator in the human cardiovascular system, Eur Heart J 1991:12:2-11.
18. Joannides R, Richard V, Haefeli WE, Linder L, Liischer TF, Thuillez C: Role of basal and stimulated release of nitric oxide in the regulation of radial artery caliber in humans, Hypertension 1995;26:327-331.
19. Rees DD, Palmer RMJ, Moncada S: Role of endothelium-derived nitric oxide in the regulation of blood pressure, Proc Natl Acad Sci USA 1989;86:3375-3378.
20. Vallancc P, Collier J, Moncada S: Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man, Lancet 1989;ii:997-1000.
21. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillcz C, Liischer TF: Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo, Circulation 1995;91:1314-1319.
22. Radomski MW, Palmer RM, Moncada S: Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium, Lancet 1987;ii: 1057-1058.
23. Radomski MW, Palmer RM, Moncada S: An L-arginine/nitric oxide pathway present in human platelets regulates aggregation, Proc Natl Acad Sci USA 1990;87:5193-5197.
24. Moreau P, Takase H, Kiing CF, van Rooijen MM, Schaffner T, Liischer TF: Structure and function of the rat basilar artery during chronic nitric oxide synthase inhibition, Stroke 1995: 26:1922-1928 (discussion 1928-1929).
25. Palmer RM, Bridge L, Foxwell NA, Moncada S: The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids, BrJ Pharmacol 1992;105:11-12.
26. Tschudi MR, Noll G, Amct U, Novosel D, Gantcn D, Liischer TF: Alterations in coronary artery vascular reactivity of hypertensive Rcn-2 transgenic rats, Circulation 1994,89: 2780-2786.
27. Haynes WG, Noon JP, Walker BR, Webb DJ: Systemic inhibition of nitric oxide synthesis increases blood pressure, Abstr Counc High Blood Pressure Res 1993;30.
28. Blot S, Amal JF, Xu Y, Gray F, Michel JB: Spinal cord infarcts during long-term inhibition of nitric oxide synthase in rats, Stroke 1994:25: 1666-1673.
29. Dubey RK, Jackson EK, Luscher TF: Nitric oxide inhibits angiotensin Il-induced migration of rat aortic smooth muscle cell, Role of cyclic-nucleotidcs and angiotensin 1 receptors, J Clin Invest 1995;96:141-149.
30. Noll G, Liischcr TF: Local regulation of vascular tone and growth, Exp Nephrol 1994;2:78- 91.
31. Liischer TF, Vanhoutte PM: Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat, Hypertension 1986;8:344-348.
32. Liischer TF, Romero JC, Vanhoutte PM: Bioassay of endothelium-derived substances in the aorta of normotensivc and spontaneously hypertensive rats, J Hvpertens 1986;4(suppl 6): 81.
33. Dohi Y, Thiel MA, Biihler FR, Liischer TF: Activation of endothelial L-arginine pathway in resistance arteries, Effect of age and hypertension, Hypertension 1990;16:170-179.
34. Diederich D, Yang ZH, Biihler FR, Liischer TF: Impaired endothelium-dependent relaxations in hypertensive resistance arteries involve cyclooxygenase pathway, Am J Physiol 1990:258:H445-H451.
35. Dohi Y, Criscione L, Liischer TF: Renovascular hypertension impairs formation of endothc-lium-derived relaxing factors and sensitivity to endothelin-1 in resistance arteries, Br J Pharmacol 1991;104:349-354.
36. Liischer TF: Heterogeneity of endothelial dys-funclion in hypertension, Eur Heart J 1992; 13 (suppl D):50-55.
37. Liischer TF, Noll G: Endothelium-dependent vasoaiotion in aging, hypertension and heart failure, Circulation 1993:87(suppl VII):97- 103.
38. Liischer TF: The endothelium in hypertension: Bystander, target or mediator? J Hypertens 1994; 12(suppl 10):105-116.
39. Kiing CF, Liischer TF: Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta, Hypertension 1995;25: 194-200.
40. Tschudi MR, Criscione L, Liischer TF: Effect of aging and hypertension on endothelial function of rat coronary arteries, J Hypertens Suppl 1991;9(suppl 6): 164-165.
41. Noll G, Lang M, Tschudi MR, Ganten D, Liischer TF: Endothelium-derived vasoconstrictor prostanoids modulate contractions to acetylcholine and angiotensin II in mesenteric resistance arteries of Ren-2 transgenic rats, Am J Physiol 1997;272:H493-H500.
42. Nava E, Leone AM, Wiklund NP, Moncada S: Detection of release of nitric oxide by vasoactive substances in the anacsthcsizcd rat; in Fcc-lisch M, Busse R, Moncada S (eds): The Biology of Nitric Oxide, London, Portland Press, 1994, pp 179-181.
43. Buga GM, Gold ME, Fukuto JM, lgnarro LI: Shear stress-induced release of nitric oxide from endothelial cells grown on beads, Hypertension 1991;17:187-193.
44. Scssa WC, Pritchard K, Seyedi N, Wang J, Hinlze TH: Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression, Circ Res 1994:74:349-353.
45. Liischer TF, Noll G, Wenzel RR: Systemic hypertension and related vascular disease; in Stchbens WE, Lie JT (eds): Vascular Pathology, London, Chapman & Hall, 1995, pp653-669.
46. Keim M, Feelisch M, Krebber T, Motz W, Straucr BE: The role of nitric oxide in the regulation of coronary vascular resistance in arterial hypertension: Comparison of normotensive and spontaneously hypertensive rats, J Car-diovasc Pharmacol 1992;20:S183-S186.
47. Nava E, Noll G, Liischcr TF: Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension, Circulation 1995;91:2310-2313.
48. Dubey RK, Ganten D, Liischer TF: Enhanced migration of vascular smooth muscle cells from Ren-2 transgenic rats in response to angiotensin II, Hypertension 1993;22:412.
49. Ohara Y, Peterson TE, Harrison DG: Hypercholesterolemia increases endothelial Superoxide anion production, J Clin Invest 1993;91: 2546-2551.
50. Nabel EG, Ganz P, Gordon JB, Alexander RW, Sehvyn AP: Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test, Circulation 1988;77:43-52.
51. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M: Does Superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sei USA 1991:88:10045-10048.
52. Tschudi MR, Mesaros S, Liischer TF, Malinski T: Direct in situ measurement of nitric oxide in mesenteric resistance arteries, Increased decomposition by supcroxide in hypertension, Hypertension 1996;27:32-35.
53. Liischer TF, Vanhoutte PM: Mechanisms of altered endothelium-dependent responses in hypertensive blood vessels: in Vanhoutte PM (ed): Relaxing and Contracting Factors, Clifton, Humana Press, 1988, pp 495-509.
54. Liischer TF, Raij L, Vanhoutte PM: Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats, Hypertension 1987;9:157-163.
55. Calvcr A, Collier J, Moncada S, Vallance P: Effect of local inlra-arterial N°-monomcthyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal, J Hypertens 1992;10:1025-1031.
56. Kiowski W, Liischer TF, Linder L, Biihler FR: Endothelin-1-induced vasoconstriction in humans, Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor, Circulation 1991:83: 469-475.
57. Panza JA, Quvyumi AA, Brush JJ, Epstein SE: Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension, N Engl J Med 1990;323:22-27.
58. Taddei S, Virdis A, Mattei P, Salvetti A: Vasodilation to acetylcholine in primary and secondary forms of human hypertension, Hypertension 1993;21:929-933.
59. Cockcroft JR, Chowienczyk PJ, Benjamin N, Ritter JM: Preserved endothelium-dependent vasodilatation in patients with essential hypertension, N Engl J Med 1994;330:1036-1040.
60. Lahera V, Salom MG, Miranda-Guardiola F, Moncada S, Romero JC: Effects of N°-nitro-L-arginine methyl ester on renal function and blood pressure, Am J Physiol 1991:261:F1033- F1037.
61. Salazar FJ, Pinilla JM, Lopez F, Romero JC, Qucsada T: Renal effects of prolonged synthesis inhibition of endothelium-derived nitric oxide, Hypertension 1992;20:113-117.
62. Vallance P, Leone A, Calver A, Collier J, Moncada S: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure, Lancet 1992;339:572-575.
63. Linder L, Kiowsky W, Biihler FR, Liischer TF: Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo, Blunted response in essential hypertension, Circulation 1990:81:1762-1767.